Trial Profile
Study of pazopanib and trabectedin vs standard chemotherapy in second line treatment of patients with metastatic soft tissue sarcomas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jun 2018
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary) ; Trabectedin (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 20 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology